Skip to main content

Advertisement

Log in

Odors identification differences in deficit and nondeficit schizophrenia

  • Original research article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

There is evidence that deficit schizophrenia (DS) is associated with neuroanatomical changes in structures including those involved in olfaction. Olfactory dysfunction, which includes impaired odor identification, is found in patients with schizophrenia and their family members.

Methods

82 patients with DS and 72 patients with NDS (nondeficit schizophrenia), somatically healthy and without acute psychotic symptoms undertook a smell identification test using the 16-item Sniffin’ Sticks ID test. Demographic and psychometric data were collected.

Results

No differences in the course of the illness, perinatal history and demographic data were found between the DS and NDS groups. No differences in the number of correctly identified odor samples were found. Some differences in the qualitative identification of samples between DS and NDS were found in the groups of female (fewer correct identifications of cinnamon and pineapple smells in DS) and male patients (fewer correct identifications of the smell of rose and more correct identifications of the smell of orange than in NDS).

Conclusions

No overall differences between DS and NDS regarding odors identification have been found. The results seem to indicate some specific deficits in the identification of markers of rose, pineapple, orange and cinnamon.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ALT:

alanine transaminase

AST:

aspartate transaminase

CNS:

central nervous system

DS:

deficit schizophrenia

DSM IV:

Diagnostic and Statistical Manual of Mental Disorders, Forth Edition

DUP:

duration of untreated psychosis

GABA:

γ-aminobutyric acid

ICD10:

International Statistical Classification of Diseases and Related Health Problems, Tenth Edition

MINI:

Mini International Neuropsychiatric Interview

NDS:

non deficit schizophrenia

OPCRIT:

Operational Criteria for Psychotic Illness

PANSS:

Positive and Negative Syndrome Scale

SDS:

Schedule for the Deficit Syndrome

S’S:

Sniffin Sticks

TSH:

thyroid-stimulating hormone

References

  1. Carpenter W, Heinrichs D, Wagman AI. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 1988;145(5):578–83.

    Article  PubMed  Google Scholar 

  2. Kirkpatrick B, Buchanan R, Ross D, Carpenter Jr. W. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 2001;58(2):165–71.

    Article  CAS  PubMed  Google Scholar 

  3. Galderisi S, Maj M. Deficit schizophrenia: an overview of clinical, biological and treatment aspects. Eur Psychiatry 2009;24(8):493–500.

    Article  CAS  PubMed  Google Scholar 

  4. Kirkpatrick B, Fenton W, Carpenter Jr. W, Marder S. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006;32(2):214–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Milev P, Ho B, Arndt S, Andreasen N. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 2005;162(3):495–506

    Article  PubMed  Google Scholar 

  6. Fenton W, McGlashan T. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry 1994;151(3):351–6.

    Article  CAS  PubMed  Google Scholar 

  7. Fenton W, McGlashan T. Testing systems for assessment of negative symptoms in schizophrenia. Arch Gen Psychiatry 1992;49(3):179–84.

    Article  CAS  PubMed  Google Scholar 

  8. Bienkowski P, Samochowiec J, Pelka-Wysiecka J, Grzywacz A, Skibinska M, Jasiewicz A, et al. Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype. Pharmacol Rep 2015;67(3):442–5.

    Article  CAS  PubMed  Google Scholar 

  9. Pełka-Wysiecka J, Wroński M, Jasiewicz A, Grzywacz A, Tybura P, Kucharska-Mazur J, et al. BDNF rs 6265 polymorphism and COMT rs 4680 polymorphism in deficit schizophrenia in Polish sample. Pharmacol Rep 2013;65(5):1185–93.

    Article  PubMed  Google Scholar 

  10. Galderisi S, Maj M, Mucci A, Cassano G, Invernizzi G, Rossi A, et al. Historical, psychopathological, neurological and neuropsychological aspects of deficit schizophrenia: a multicenter study. Am J Psychiatry 2002;159(6):983–90.

    Article  PubMed  Google Scholar 

  11. Kirkpatrick B, Conley R, Kakoyannis A, Reep R, Roberts R. Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 1999;34(2):95–102.

    Article  CAS  PubMed  Google Scholar 

  12. Kirkpatrick B, Messias N, Conley R, Roberts R. Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J Nerv Ment Dis 2003;19(9):563–7.

    Article  Google Scholar 

  13. Moberg P, Agrin R, Gur R, Turetsky B, Doty R. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology 1999;21(3):325–40.

    Article  CAS  PubMed  Google Scholar 

  14. Stockhorst U, Pietrowsky R. Olfactory perception, communication, and the nose-to-brain pathway. Physiol Behav 2004;83(1):3–11.

    Article  CAS  PubMed  Google Scholar 

  15. Kosaka T, Kosaka K. Interneurons in the olfactory bulb revisited. Neurosci Res 2011;69(2):93–9.

    Article  CAS  PubMed  Google Scholar 

  16. Barresi M, Ciurleo R, Giacoppo S, Foti Cuzzola V, Celi D, Bramanti P, et al. Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci 2012;323(1–2):16–24.

    Article  PubMed  Google Scholar 

  17. Kayser J, Tenke C, Kroppmann C, Alschuler D, Ben-David S, Fekri S, et al. Olfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection. Int J Psychophysiol 2013;90(2):190–206.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Moberg P, Kamath V, Marchetto D, Calkins M, Doty R, Hahn C, et al. Metaanalysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis. Schizophr Bull 2014;40(1):50–9.

    Article  PubMed  Google Scholar 

  19. Kopala L, Clark C, Hurwitz T. Olfactory deficits in neuroleptic naive patients with schizophrenia. Schi Res 1992;8(3):245–50.

    Article  Google Scholar 

  20. Moberg P, Doty R, Turetsky B, Arnold S, Mah R, Gur R, et al. Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry 1997;154(7):1016–8.

    Article  CAS  PubMed  Google Scholar 

  21. Kamath V, Turetsky B, Calkins M, Kohler C, Conroy C, Borgmann-Winter K, et al. Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. World J Biol Psychiatry 2011;10:1–10.

    Article  Google Scholar 

  22. Brewer W, Pantelis C, Anderson V, Velakoulis D, Singh B, Copolov D, et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry 2001;158(1):107–15.

    Article  CAS  PubMed  Google Scholar 

  23. Martzke J, Kopala L, Good K. Olfactory dysfunction in neuropsychiatric disorders: review and methodological considerations. Biol Psychiatry 1997;42(8):721–32.

    Article  CAS  PubMed  Google Scholar 

  24. Geddes J, Huws R, Pratt P. Olfactory acuity in the positive and negative syndromes of schizophrenia. Biol Psychiatry 1991;29(8):774–8.

    Article  CAS  PubMed  Google Scholar 

  25. Brewer W, Edwards J, Anderson V, Robinson T, Pantelis C. Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biol Psychiatry 1996;40(10):1021–31.

    Article  CAS  PubMed  Google Scholar 

  26. Seckinger R, Goudsmit N, Coleman E, Harkavy-Friedman J, Yale S, Rosenfield PJ, et al. Olfactory identification and WAIS-R performance in deficit and non-deficit schizophrenia. Schizophr Res 2004;69(1):55–65.

    Article  PubMed  Google Scholar 

  27. Malaspina D, Coleman E, Goetz R, Harkavy-Friedman J, Corcoran C, Amador X, et al. Odor identification, eye tracking and deficit syndrome schizophrenia. Biol Psychiatry 2002;51(10):809–15.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Strauss G, Allen D, Ross S, Duke L, Schwartz J. Olfactory hedonic judgment in patients with deficit syndrome schizophrenia. Schizophr Bull 2010; 36(4):860–8.

    Article  PubMed  Google Scholar 

  29. Jarema M, Kiejna A, Landowski J, Meder J, Rabe-Jablonska J, Rybakowski J. Pharmacological standards. In: Schizophrenia treatment. Psychiatr Pol 2006;40:1171–205.

    PubMed  Google Scholar 

  30. Tybura P, Samochowiec A, Beszlej A, Grzywacz A, Mak M, Frydecka D, et al. Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients. Pharmacol Rep 2012;64(3): 528–35.

    Article  CAS  PubMed  Google Scholar 

  31. Jaracz J, Tetera-Rudnicka E, Kujath D, Raczyńska A, Stoszek S, Czernaś W, et al. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland. Pharmacol Rep 2014;66(4):613–7.

    Article  PubMed  Google Scholar 

  32. Jarema M, Wichniak A, Dudek D, Samochowiec J, Bieńkowski P, Rybakowski J. Guidelines for the use of second-generation long-acting antipsychotics. Psychiatr Pol 2015;49(2):225–41.

    Article  PubMed  Google Scholar 

  33. Sawicka M, Charzyńska K. The role of a psychiatrist in treatment and recovery process of persons suffering from schizophrenia. Psychiatr Pol 2015;49(2):377–89.

    Article  PubMed  Google Scholar 

  34. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991;48(8):764–70.

    Article  CAS  PubMed  Google Scholar 

  35. Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22–33.

    PubMed  Google Scholar 

  36. Leucht S, Kissling W, Davis J. The PANSS should be rescaled. Schizophr Bull 2010;36(3):461–2.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kirkpatrick B, Buchanan R, McKenney P, Alphs L, Carpenter W. The Schedule for the Deficit Syndrome: an instrument for research in schizophrenia. Psychiatry Res 1989;30(2):119–24.

    Article  CAS  PubMed  Google Scholar 

  38. Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the Sniffin’ Sticks including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 2007;264(3):237–43.

    Article  CAS  PubMed  Google Scholar 

  39. Hummel T, Sekinger B, Wolf S, Paul E, Kobal G. Sniffin’ Sticks: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997;22(1):39–52.

    Article  CAS  PubMed  Google Scholar 

  40. Temmel A, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002;128(6):635–41.

    Article  PubMed  Google Scholar 

  41. McKinnon J, Demaerschalk BM, Caviness JN, Wellik KE, Adler CH, Wingerchuk DM. Sniffing out Parkinson disease: can olfactory testing differentiate Parkinsonian disorders? Neurologist 2007;13(6):382–5.

    Article  PubMed  Google Scholar 

  42. Urban M, Rabe-Jabłońska J. Olfactory dysfunctions in patients with schizophrenia. Psychiatr Pol 2007;41(4):503–12.

    PubMed  Google Scholar 

  43. Scinska A, Wrobel E, Korkosz A, Zatorski P, Sienkiewicz-Jarosz H, Lojkowska W, et al. Depressive symptoms and olfactory function in older adults. Psychiatry Clin Neurosci 2008;62(4):450–6.

    Article  PubMed  Google Scholar 

  44. Swiecicki L, Zatorski P, Bzinkowska D, Sienkiewicz-Jarosz H, Szyndler J, Scinska A. Gustatory and olfactory function in patients with unipolar and bipolar depression. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(5):827–34.

    Article  PubMed  Google Scholar 

  45. Kopala L, Good K, Honer W. Olfactory identification ability in pre- and postmenopausal women with schizophrenia. Biol Psychiatry 1995;38(1):57–63.

    Article  CAS  PubMed  Google Scholar 

  46. Coleman E, Goetz R, Leitman D, Yale S, Stanford A, Gorman J, et al. Odor identification impairments in schizophrenia: relationship with demographic measures, clinical variables, and diagnostic subtypes. CNS Spectr 2002;7(1):43–8.

    Article  PubMed  Google Scholar 

  47. Good KP, Whitehorn D, Rui Q, Milliken H, Kopala L. Olfactory identification deficits in first-episode psychosis may predict patients at risk for persistent negative and disorganized or cognitive symptoms. Am J Psychiatry 2006;163(5):932–3.

    Article  PubMed  Google Scholar 

  48. Kopala L, Good K, Honer W. Olfactory hallucinations and olfactory identification ability in patients with schizophrenia and other psychiatric disorders. Schizophr Res 1994;12(3):205–11.

    Article  CAS  PubMed  Google Scholar 

  49. Malaspina D, Perera G, Lignelli A, Marshall R, Esser P, Storer S, et al. SPECT imaging of odor identification in schizophrenia. Psychiatry Res 1998;82(1):53–61.

    Article  CAS  PubMed  Google Scholar 

  50. Wu J, Buchsbaum M, Moy K, Denlea N, Kesslak P, Tseng H, et al. Olfactory memory in unmedicated schizophrenics. Schizophrenia Res 1993;9(1):41–7.

    Article  CAS  Google Scholar 

  51. Kopala L, Good K, Morrison K, Basset A, Alda M, Honer W. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry 2001;158(8):1286–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Cohen A, Brown L, Auster T. Olfaction, “olfiction”, and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity. Schizophr Res 2012;135(1–3):152–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jerzy Samochowiec.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pełka-Wysiecka, J., Wroński, M., Bieńkowski, P. et al. Odors identification differences in deficit and nondeficit schizophrenia. Pharmacol. Rep 68, 390–395 (2016). https://doi.org/10.1016/j.pharep.2015.11.001

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2015.11.001

Keywords

Navigation